Literature DB >> 19214416

Prognostic value of heart rate variability after acute myocardial infarction in the era of immediate reperfusion.

Ali Erdogan1, Michael Coch, Mehmet Bilgin, Mariana Parahuleva, Harald Tillmanns, Bernd Waldecker, Nedim Soydan.   

Abstract

INTRODUCTION: The incidence and significance of impaired heart rate variability (HRV) after acute myocardial infarction (AMI) have not yet been evaluated in cohorts of patients in whom early reperfusion was systematically attempted. Therefore, HRV was evaluated in 412 unselected patients with AMI (311 men, mean age: 60+/-12 years, anterior AMI in 172 patients) treated with direct coronary angioplasty (PTCA) within 12 hours of symptom onset (mean 3.5+/-2.0 h). Standard deviation of normal RR intervals (SDNN), square root of the mean of the sum of the squares of differences between adjacent RR intervals (RMSSD) and left ventricular ejection fraction (LVEF, mean: 55+/-15%) were measured 11+/-9 days after AMI before discharge. Angiotensin-converting enzyme (ACE) inhibitors and beta-blockers were prescribed at discharge in 81.1% and 70.1% of patients, respectively.
RESULTS: Mean SDNN was 94+/-30 ms (range 14-155). SDNN was <50 ms in 7% of patients. Mean RMSSD was 34+/-32 ms (range 2-234). RMSSD was <15 ms in 21% of patients. Low SDNN (<50 ms) was unrelated to gender, age, infarct location or extension of CHD but was related to low LVEF (p<0.001, logistic regression analysis). During mean follow-up of 4.3+/-3 years, there were 31 deaths; 24 were cardiac. SDNN was higher in long-term survivors (102+/-39 ms) as compared to nonsurvivors (81+/-33 ms, p=0.02) but RMSSD was unrelated to the long-term vital status. Four-year survival of patients with a SDNN <50 ms vs >50 ms was 80% vs 92%, respectively (p<0.001, Kaplan Meier analysis). Low SDNN (odds ratio OR=2.0, p<0.05) but not RMSSD was an independent denominator for long-term mortality as were low LVEF (OR=1.0 decrease in LVEF, p<0.01, proportional hazards model) and age (OR=1.1, p<0.001). Only 3/31 fatalities and 1/24 cardiac deaths were predicted by a SDNN <50 ms and only 5/31 fatalities by a RMSSD <15 ms.
CONCLUSION: The incidence of severely depressed HRV in patients after AMI is low (<10%) in the era of early reperfusion of the infarct vessel using direct PTCA. Mortality in patients with a very low HRV when assessed by SDNN is substantial but the positive predictive value of this parameter is low.

Entities:  

Mesh:

Year:  2009        PMID: 19214416     DOI: 10.1007/s00399-008-0024-3

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  35 in total

1.  Efficient estimation of the heart period power spectrum suitable for physiologic or pharmacologic studies.

Authors:  J N Rottman; R C Steinman; P Albrecht; J T Bigger; L M Rolnitzky; J L Fleiss
Journal:  Am J Cardiol       Date:  1990-12-15       Impact factor: 2.778

Review 2.  Heart rate variability.

Authors:  M Malik; A J Camm
Journal:  Clin Cardiol       Date:  1990-08       Impact factor: 2.882

3.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

4.  Preservation of autonomic function following successful reperfusion with streptokinase within 12 hours of the onset of acute myocardial infarction.

Authors:  P A Kelly; J Nolan; J I Wilson; E J Perrins
Journal:  Am J Cardiol       Date:  1997-01-15       Impact factor: 2.778

5.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

6.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Authors:  R E Kleiger; J P Miller; J T Bigger; A J Moss
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

7.  Components of heart rate variability measured during healing of acute myocardial infarction.

Authors:  J T Bigger; R E Kleiger; J L Fleiss; L M Rolnitzky; R C Steinman; J P Miller
Journal:  Am J Cardiol       Date:  1988-02-01       Impact factor: 2.778

8.  Heart rate variability in the early hours of an acute myocardial infarction.

Authors:  F Lombardi; G Sandrone; M T Spinnler; D Torzillo; G C Lavezzaro; A Brusca; A Malliani
Journal:  Am J Cardiol       Date:  1996-05-15       Impact factor: 2.778

9.  Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.

Authors:  N Singh; D Mironov; P W Armstrong; A M Ross; A Langer
Journal:  Circulation       Date:  1996-04-01       Impact factor: 29.690

10.  A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.

Authors: 
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

View more
  9 in total

1.  Influence of an Early Mobilization Protocol on the Autonomic Behavior of Patients Undergoing Percutaneous Transluminal Coronary Angioplasty.

Authors:  Bárbara Oliveira Silveira; Jade Lara de Melo; Graziella Paula de Oliveira Neri; Michele Lima Gregório; Moacir Fernandes de Godoy; Marilita Falangola Accioly
Journal:  Arq Bras Cardiol       Date:  2021-12       Impact factor: 2.667

2.  Are the Associations of Cardiac Acceleration and Deceleration Capacities With Fine Metal Particulate in Welders Mediated by Inflammation?

Authors:  Peter E Umukoro; Jason Y Y Wong; Jennifer M Cavallari; Shona C Fang; Chensheng Lu; Xihong Lin; Murray A Mittleman; Georg Schmidt; David C Christiani
Journal:  J Occup Environ Med       Date:  2016-03       Impact factor: 2.162

3.  Clinical application of heart rate variability after acute myocardial infarction.

Authors:  Heikki V Huikuri; Phyllis K Stein
Journal:  Front Physiol       Date:  2012-02-27       Impact factor: 4.566

4.  Does heart rate variability correlate with long-term prognosis in myocardial infarction patients treated by early revascularization?

Authors:  Leonida Compostella; Nenad Lakusic; Caterina Compostella; Li Van Stella Truong; Sabino Iliceto; Fabio Bellotto
Journal:  World J Cardiol       Date:  2017-01-26

5.  Short-term metal particulate exposures decrease cardiac acceleration and deceleration capacities in welders: a repeated-measures panel study.

Authors:  Peter E Umukoro; Jennifer M Cavallari; Shona C Fang; Chensheng Lu; Xihong Lin; Murray A Mittleman; David C Christiani
Journal:  Occup Environ Med       Date:  2015-12-07       Impact factor: 4.402

6.  Machine Learning Improves Risk Stratification After Acute Coronary Syndrome.

Authors:  Paul D Myers; Benjamin M Scirica; Collin M Stultz
Journal:  Sci Rep       Date:  2017-10-04       Impact factor: 4.379

7.  High-frequency power of heart rate variability can predict the outcome of thoracic surgical patients with acute respiratory distress syndrome on admission to the intensive care unit: a prospective, single-centric, case-controlled study.

Authors:  I-Chen Chen; Chew-Teng Kor; Ching-Hsiung Lin; Jane Kuo; Jang-Zern Tsai; Wen-Je Ko; Cheng-Deng Kuo
Journal:  BMC Anesthesiol       Date:  2018-04-02       Impact factor: 2.217

8.  Residual heart rate variability measures can better differentiate patients with acute myocardial infarction from patients with patent coronary artery.

Authors:  Jiunn-Song Jiang; Chew-Teng Kor; David Dar Kuo; Ching-Hsiung Lin; Chia-Chu Chang; Gau-Yang Chen; Cheng-Deng Kuo
Journal:  Ther Clin Risk Manag       Date:  2018-10-08       Impact factor: 2.423

9.  Heart rate variability and incidence of depression during the first six months following first myocardial infarction.

Authors:  Alina Wilkowska; Andrzej Rynkiewicz; Joanna Wdowczyk; Jerzy Landowski; Wiesław Jerzy Cubała
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-10       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.